Collaborative Screen Program Clause Samples

Collaborative Screen Program. The parties will collaborate in the development and validation of Collaborative Screens as part of a CSP during the Collaborative Term. For the Initial Period, Roche and Aurora will collaborate with the intention to develop ***as listed in Exhibit A***, the *** under the terms described in further detail in Section 2.6. The Parties will mutually agree in writing to the nature *** therefore during the ***as outlined in Section 2.1.2 and Section 2.2.3, respectively. ***Confidential Treatment Requested 14
View Source
Collaborative Screen Program. For a period of *** years following the Effective Date, the parties will collaborate in developing and validating Collaborative Screens as part of a development program (a "Collaborative Screen Program" or a "CSP"), as follows:
View Source
Collaborative Screen Program. 10 3.1. Collaborative Screen Program. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 3.2. Access to the Aurora Reporter System Technology and Aurora Reporter System Patent Rights. . .
View Source
Collaborative Screen Program. For a period of ***following the Effective Date, the parties will collaborate in the development and validation of Collaborative Screens as part of a development program (the "Collaborative Screen Program or CSP"). P&U and Aurora will collaborate to develop Collaborative Screens at Aurora for high throughput screening during the Collaborative Period.
View Source

Related to Collaborative Screen Program

  • Development Program A. Development activities to be undertaken (Please break activities into subunits with the date of completion of major milestones) B. Estimated total development time

  • Research Program The term “

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Plan The Parties recognize that the Research Plan describes the collaborative research and development activities they will undertake and that interim research goals set forth in the Research Plan are good faith guidelines. Should events occur that require modification of these goals, then by mutual agreement the Parties can modify them through an amendment, according to Paragraph 13.6.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services